Poster Abstract Session:
251. Adolescent Vaccines
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Pediatric ID


Presentations:
Pertussis Vaccine Effectiveness and Waning Immunity in Alberta, Canada: 2004-2015
Christopher A. Bell, MPH; Steven J. Drews, PhD; Kimberley A. Simmonds, PhD; Lawrence W. Svenson, PhD; Natasha S Crowcroft, MD, PhD; Kevin Schwartz, MD, MSc; Jeffrey C. Kwong, MD; Salah Mahmud, Ph.D.; Margaret L. Russell, MD PhD
Is Category B Working? Uptake Patterns of Meningococcal Group B Vaccine among US Adolescents and Young Adults
Farid L. Khan, MPH; David L. Swerdlow, MD; Laura J. York, PhD; Paul Balmer, PhD; Raul E. Isturiz, MD; John M. McLaughlin, PhD
Immunogenicity and Safety of a MenACWY-CRM Booster Dose 4-6 Years after Primary Quadrivalent Meningococcal Conjugate Vaccination in Healthy U.S. Adolescents and Adults
Mary Tipton, MD; Wendy Daly, MD; Shelly Senders, MD; Stanley L. Block, MD; Pavitra Keshavan, MBSS, PhD; Thembile Mzolo, PhD; Michele Pellegrini, MD, PhD
Multivariate Analyses of Socio-economic Inequities in Parental Awareness and Utilization of Meningococcal Serogroup B Vaccines
Liping Huang, MD, MPH; Amanda Dempsey, MD, PhD, MPH; Alex Galitsky, BA; Mansour Fahimi, PhD; Amit Srivastava, PhD
Disparities in Healthcare Providers’ Interpretation and Implementation of ACIP’s Meningococcal Vaccine Recommendations
Liping Huang, MD, MPH; Amir Goren, PhD; Lulu Lee, PhD; Amanda Dempsey, MD, PhD, MPH; Amit Srivastava, PhD
Meningococcal ACWY (MenACWY) Vaccination of Adolescents in the US: How Compliant Are We with the Advisory Committee on Immunization Practices (ACIP) Recommendations?
Wendy Cheng, MPH, MPhil; Rose Chang, MSPH, MS, ScD; Patricia Novy, PhD; Cristi O'Connor, MHS; Mei Sheng Duh, MPH, ScD; Cosmina Hogea, PhD
Posters
  • IDWeek_2459_e-poster.pdf (530.3 kB)
  • Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents
    Tanya Myers, PhD, MSc; Eric Weintraub, MPH; Michael McNeil, MD, MPH; Lakshmi Sukumaran, MD, MPH; Jonathan Duffy, MD; Roger Baxter, MD, FIDSA; Nicola P. Klein, MD, PhD; Matthew F. Daley, MD; James Donahue, DVM, PhD; Hung Fu Tseng, PhD, MPH; Stephanie Irving, MHS; Michael L. Jackson, PhD, MPH; Saad Omer, MBBS, MPH, PhD, FIDSA
    Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Individuals 56 Years of Age and Older
    Robert Jeanfreau, MD; Alejandra Esteves-Jaramillo, MD, MPH; David Neveu, Pharmacist; Emilia Jordanov, MD; Mandeep S Dhingra, MD
    Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014-2017
    Jorge Arana, MD, MPH; John Su, MD, MPH; Paige Lewis, MSPH; Maria Cano, MD, MPH; Lauri E. Markowitz, MD; Tom Shimabukuro, MD, MPH, MBA
    A Significant Portion of College Students are not Aware of HPV Disease and HPV Vaccine Recommendations
    Jessica Leyva, Expected: Bachelor's Degree; Elizabeth Sanchez, Expected: Bachelor's Degree; Ayana Arroyo, Expected: Bachelor's Degree; Kasia Wade, Expected: Bachelor's Degree; NgocTuyen Dinh, Expected: Bachelor's Degree; Caitlyn Kellogg, BA; Ozlem Equils, MD
    Posters
  • MiOra HPV Poster 10042018-8.pdf (279.1 kB)
  • A Pilot Program to Improve Human Papillomavirus Vaccination Status of Adolescents at a School-Based Health Center
    Caitlin Hansen, MD; Anna North, MPH; Alison Moriarty-Daley, PhD, APRN; Linda M. Niccolai, PhD ScM

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.